This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Evaluating Exact Sciences Cancerguard multi-cancer blood test
Ticker(s): EXASWho's the expert?
Institution: University of Colorado Hospital
- A board-certified medical oncologist and a Professor of Medical Oncology in the Department of Medicine at the University of Colorado School of Medicine.
- Manages 350 patients with multiple primary cancer
- Current investigator of Exact sciences' Cancerguard multi cancer blood test member of the University of Colorado Cancer Center.
Interview GoalThe conversation will explore the potential of Exact Sciences’ Cancerguard multi-cancer blood test, including its clinical significance, how it compares with existing screening and diagnostic tools, its implications for early cancer detection, key safety and performance considerations, and the anticipated next steps in its development and adoption.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
